CANDY ATKINSON: Open Payments
NPI 1699495408 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 44 payments from 13 companies in 2025. Trend: 2023 $2,824 · 2024 $1,928 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $179 |
| ABBVIE INC. | 12 | $157 |
| Novo Nordisk Inc | 6 | $119 |
| PFIZER INC. | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, QULIPTA, SHINGRIX, NURTEC ODT, Ozempic, VRAYLAR, Wegovy, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
